Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: Case report and literature review

被引:34
作者
Chiu, MJ
Chang, YC
Hsiao, TY
机构
[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei 100, Taiwan
关键词
botulinum toxin type A; cricopharyngeus muscle spasm; dysphagia; deglutition; deglutition disorders;
D O I
10.1007/s00455-003-0029-3
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 [耳鼻咽喉科学];
摘要
Cricopharyngeus (CP) muscle spasm can lead to severe dysphagia. Myotomy of the CP muscle was the treatment of choice. Recently, botulinum toxin type A (BtxA) has been used for CP spasm. It usually brings improvement in deglutition but most patients require reinjection in 3-5 months. We report a 35-year-old man who had an arteriovenous malformation hemorrhage in the brain stem resulting in CP spasm and consequently severe dysphagia. He received BtxA injection and deglutition and nutrition remained good one year after treatment. A literature review analyzing 28 patients and our patient showed negative correlations between age and BtxA dose and between age and duration. Efficacy was positively correlated with duration and BtxA dose was positively correlated with pretreatment severity. In conclusion, physicians would use higher doses on patients with more severe cases but use lower doses on older patients. Those who obtained better post-treatment results would enjoy longer effective duration. Thus, the effective duration of the BtxA is multifactorial.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 28 条
[1]
Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia [J].
Ahsan, SF ;
Meleca, RJ ;
Dworkin, JP .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (05) :691-695
[2]
BOTULINUM-INDUCED ALTERATION OF NERVE-MUSCLE INTERACTIONS IN THE HUMAN ORBICULARIS OCULI FOLLOWING TREATMENT FOR BLEPHAROSPASM [J].
ALDERSON, K ;
HOLDS, JB ;
ANDERSON, RL .
NEUROLOGY, 1991, 41 (11) :1800-1805
[3]
Atkinson SI, 1997, J OTOLARYNGOL, V26, P273
[4]
INTERACTION OF I-125 LABELED BOTULINUM NEUROTOXINS WITH NERVE-TERMINALS .2. AUTORADIOGRAPHIC EVIDENCE FOR ITS UPTAKE INTO MOTOR NERVES BY ACCEPTOR-MEDIATED ENDOCYTOSIS [J].
BLACK, JD ;
DOLLY, JO .
JOURNAL OF CELL BIOLOGY, 1986, 103 (02) :535-544
[5]
BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25 [J].
BLASI, J ;
CHAPMAN, ER ;
LINK, E ;
BINZ, T ;
YAMASAKI, S ;
DECAMILLI, P ;
SUDHOF, TC ;
NIEMANN, H ;
JAHN, R .
NATURE, 1993, 365 (6442) :160-163
[6]
Blitzer A, 1997, OTOLARYNG HEAD NECK, V116, P328
[7]
BLITZER A, 1997, OP TECH OTOLARYNGOL, V8, P191
[8]
Cricopharyngeal dysfunction in Parkinson's disease: Role in dysphagia and response to myotomy [J].
Born, LJ ;
Harned, RH ;
Rikkers, LF ;
Pfeiffer, RF ;
Quigley, EMM .
MOVEMENT DISORDERS, 1996, 11 (01) :53-58
[9]
BRANDYPADHYAY S, 1987, J BIOL CHEM, V262, P2660
[10]
PATHOPHYSIOLOGY OF SPASTICITY [J].
BROWN, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (07) :773-777